Sintx Technologies (SINT) - Debt to Equity

SINT (SINTX Technologies) - company brandmark

Sintx Technologies (SINT) ceramic production capacities are operating seamlessly due to regular equipment maintenance. Meanwhile, trade barriers are increasing the cost of implant components, although demand for protective materials in the defense sector is rising. Market dynamics for the securities reflect a total debt-to-equity ratio of 0.63, while the company actively implements environmental standards and transparent management principles.

Sintx Technologies Inc - SINT Debt to Capital (period 07/04/2022 - 10/28/2026)
Flagship merchandise of Sintx Technologies, Inc.

Investors must evaluate the financial stability of Sintx Technologies (SINT) by analyzing the ratio of total liabilities to equity to filter out risks of excessive leverage. As medical ceramics production adapts to the market, this metric compares the market value of equity with total debt, confirming that the team's unique technical foundation ensures business reliability even during the scaling of operational activities.

Main competitors

BSX: Debt to Equity|Total Debt to Capital Coefficient EW|RMD - Debt to Equity|Aggregate Debt to Equity Insulet Inc. (PODD)|ZBH: Total Debt to Capital|Debt to Capital coopercos.com COO|ALGN: Total Debt to Capital|GMED - Total Debt to Equity Ratio|TransMedics - Total Debt to Capital|Alphatec Corp (ATEC) - Total Debt to Capital Coefficient|AORT (Artivion, Inc.) - Total Debt to Capital|Total Debt to Capital ENOV|Debt to Equity Integra LifeSciences Holdings Corporation (IART)|Debt to Equity Establishment Labs Corp (ESTA)|Total Debt to Capital BBNX|IRMD - Total Debt to Capital Coefficient|Total Debt to Equity Ratio Embecta Corp.|TNDM - Aggregate Debt to Equity|Total Debt to Capital AXGN|SI-BONE Inc (SIBN) - Debt to Capital|Total Debt to Capital Orthofix International (OFIX)|Debt to Equity Ratio Bioventus Global (BVS)|OrthoPediatrics Corp. (KIDS) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio TMCI (treace.com)|Strata Critical Medical - Debt to Equity|Total Debt to Equity Ratio Carlsmed, Inc. CARL|RXST (RxSight Corp) - Total Debt to Capital|CLPT - Debt to Capital|Total Debt to Capital Stereotaxis, Inc.|neurostar.com (STIM) - Debt to Equity Ratio|SGHT: Total Debt to Capital|Total Debt to Capital Coefficient Orchestra BioMed Inc.|Total Debt to Capital ANIK (Anika Therapeutics)|Total Debt to Equity Ratio InspireMD Inc. (NSPR)|Total Debt to Capital ZJYL (Jin Medical)|Vivani Medical Inc - Total Debt to Capital|XTNT - Debt to Equity|NeuroOne (NMTC) - Debt to Equity|Total Debt to Equity Ratio modular-medical.com MODD|Myomo Inc (MYO) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital COCH (Envoy Medical, Inc.)|Debt to Capital VVOS|NVNO: Debt to Equity|Debt to Capital Ratio Tenon Medical Inc. TNON|Total Debt to Equity Ratio LFWD (ReWalk Robotics Ltd)|Total Debt to Capital Autonomix Medical Inc. AMIX|Total Debt to Capital IVF (INVO Fertility Inc)|BBLG: Total Debt to Capital Coefficient|Debt to Equity Axonics (AXNX)|BIOL (BIOLASE Inc.) - Aggregate Debt to Equity|Debt to Equity DYNT|Total Debt to Equity Ratio Paragon 28 Corp|INVO Bioscience, Inc. - Total Debt to Capital